Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tramadol--present and future.

E A Shipton1

  • 1Department of Anaesthesiology and Pain Management, CH Baragwanath Hospital, University of the Witwatersrand, Johannesburg, South Africa.

Anaesthesia and Intensive Care
|September 2, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The transition from acute to chronic post surgical pain.

Anaesthesia and intensive care·2011
Same author

Basophilic stippling of the red corpuscles with special reference to its occurrence during chrysotherapy.

The Medical journal of Australia·2010
Same author

The treatment of rheumatoid and infective arthritis by the sulphonamides, with special reference to proseptasine, sulphadiazine and sulphaguanidine.

Rheumatism·2010
Same author

The treatment of rheumatoid and infective arthritis by the sulphonamides, with special reference to proseptasine, sulphadiazine and sulphaguanidine.

The Medical journal of Australia·2010
Same author

The beneficial effects of yeast in diabetes mellitus.

The Medical journal of Australia·2010
Same author

In-hospital cardiac arrest: different wards show different survival patterns.

Anaesthesia and intensive care·2007

Tramadol, an atypical opioid, offers effective pain relief for various conditions with a favorable safety profile. Its unique properties make it suitable for both short-term and long-term use in diverse patient populations.

Area of Science:

  • Pharmacology
  • Pain Management
  • Drug Safety

Background:

  • Tramadol, an atypical opioid, is now available in Australia and New Zealand.
  • It presents a user-friendly profile for managing acute and chronic pain.
  • Its multi-formulation availability and low serious side-effect potential are key features.

Purpose of the Study:

  • To provide a comprehensive review of tramadol's characteristics and clinical applications.
  • To evaluate its efficacy, safety, and unique pharmacological profile.
  • To discuss its potential in various patient groups and future therapeutic uses.

Main Methods:

  • Review of tramadol's formulation, administration routes, and enantiomeric biochemistry.
  • Analysis of its triple mechanisms of action, pharmacokinetics, and pharmacodynamics.

Related Experiment Videos

  • Comparison of analgesic efficacy, safety profile, and adverse events with other opioids.

    • Main Results:

    • Tramadol demonstrates efficacy across diverse acute and chronic pain states, including cancer pain.
    • It exhibits a favorable safety profile with relatively low risk of respiratory depression, organ toxicity, and histamine release.
    • Specific considerations for elderly, pediatric, and obstetric patients are discussed.

    Conclusions:

    • Tramadol offers a valuable therapeutic option for pain management due to its efficacy and favorable safety.
    • Its unique pharmacological properties and low dependence potential contribute to its user-friendly profile.
    • Further research into new uses and future expectations for tramadol is warranted.